RiaSTAP

Generic name: Fibrinogen
Drug class: Miscellaneous coagulation modifiers

Usage of RiaSTAP

RiaSTAP is a man-made form of a protein that occurs naturally in the body and helps the blood to clot.

RiaSTAP is used to treat bleeding episodes in people with a congenital fibrinogen deficiency.

RiaSTAP may also be used for purposes not listed in this medication guide.

RiaSTAP side effects

Get emergency medical help if you have any signs of an allergic reaction to RiaSTAP: hives, rash; tightness in your chest; wheezing, difficult breathing; feeling like you might pass out; swelling of your face, lips, tongue, or throat.

Stop using RiaSTAP and call your doctor at once if you have:

signs of a stroke--sudden numbness or weakness (especially on one side of the body), sudden severe headache, slurred speech, problems with vision or balance;

signs of a blood clot in the lung--chest pain, sudden cough, wheezing, rapid breathing, coughing up blood;

signs of a blood clot in your leg--pain, swelling, warmth, or redness in one or both legs; or

heart attack symptoms--chest pain or pressure, pain spreading to your jaw or shoulder, nausea, sweating.

Common RiaSTAP side effects may include:

fever; or

headache.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking RiaSTAP

You should not use RiaSTAP if you are allergic to fibrinogen, or if you have ever had a severe allergic reaction.

To make sure RiaSTAP is safe for you, tell your doctor if you have:

a history of stroke or blood clot.

It is not known whether RiaSTAP will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medicine.

It is not known whether fibrinogen passes into breast milk or if it could harm a nursing baby. Tell your doctor if you are breast-feeding a baby.

RiaSTAP is made from human plasma (part of the blood) which may contain viruses and other infectious agents. Donated plasma is tested and treated to reduce the risk of it containing infectious agents, but there is still a small possibility it could transmit disease. Talk with your doctor about the risks and benefits of using this medication.

Relate drugs

How to use RiaSTAP

Usual Adult Dose for Congenital Fibrinogen Deficiency:

Dose when fibrinogen level is unknown: Dose (mg/kg body weight) = [Target level (mg/dL) - measured level (mg/dL)]/1.7 (mg/dL per mg/kg body weight) Dose when fibrinogen level is unknown: Dose = 70 mg/kg body weight. The injection rate should not exceed 5 mL per minute.

Warnings

You should not use RiaSTAP if you are allergic to fibrinogen, or if you have ever had a severe allergic reaction.

If you have certain conditions, you may need a dose adjustment or special tests to safely use this medication. Before using RiaSTAP, tell your doctor if you have a history of stroke or blood clot.

Do not self-inject RiaSTAP if you do not fully understand how to give the injection and properly dispose of needles, IV tubing, and other items used in giving the medicine. This medicine comes with patient instructions for safe and effective use. Follow these directions carefully. Ask your doctor or pharmacist if you have any questions.

RiaSTAP is made from human plasma (part of the blood) and may contain viruses and other infectious agents that can cause disease. Although donated human plasma is screened, tested, and treated to reduce the risk of it containing anything that could cause disease, there is still a small possibility it could transmit disease. Talk with your doctor about the risks and benefits of using this medication.

What other drugs will affect RiaSTAP

Other drugs may interact with fibrinogen, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell each of your health care providers about all medicines you use now and any medicine you start or stop using.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.